Baxter Healthcare Corporation
GPTKB entity
Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:José_E._Almeida
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:division |
Pharmaceuticals
Clinical Nutrition Medical Products Acute Therapies Advanced Surgery BioPharma Solutions Medication Delivery Renal Care |
| gptkbp:ESRB_rating |
included in Dow Jones Sustainability Index
|
| gptkbp:focusArea |
nutrition
critical care hospital care surgical care renal care |
| gptkbp:founded |
1931
|
| gptkbp:founder |
gptkb:Donald_Baxter
|
| gptkbp:headquartersLocation |
gptkb:Deerfield,_Illinois,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Baxter Healthcare Corporation
|
| gptkbp:industry |
healthcare
pharmaceuticals medical devices |
| gptkbp:listedOn |
gptkb:Fortune_500
|
| gptkbp:notableAcquisition |
gptkb:Gambro
gptkb:Hillrom Claris Injectables Seprafilm |
| gptkbp:notableEvent |
acquired Gambro in 2013
acquired Hillrom in 2021 spun off Baxalta in 2015 |
| gptkbp:notableProduct |
Advate (hemophilia treatment)
Claris Injectables portfolio Floseal Hemostatic Matrix HomeChoice automated peritoneal dialysis system Nexterone (amiodarone injection) Oxiris blood purification set Prismaflex System SIGMA Spectrum Infusion System Tisseel Fibrin Sealant |
| gptkbp:numberOfEmployees |
~60,000
|
| gptkbp:parentCompany |
gptkb:Baxter_International_Inc.
|
| gptkbp:product |
IV solutions
anesthesia products infusion systems renal care products hospital equipment injectable pharmaceuticals biosurgery products |
| gptkbp:publiclyTraded |
true
|
| gptkbp:revenue |
$15.1 billion (2022)
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:spinOff |
gptkb:Baxalta
|
| gptkbp:stockExchange |
gptkb:NYSE
|
| gptkbp:stockSymbol |
gptkb:BAX
|
| gptkbp:subsidiary |
gptkb:Gambro
Hillrom (acquired 2021) |
| gptkbp:website |
https://www.baxter.com/
|
| gptkbp:bfsParent |
gptkb:Team_16_(Bomb_Squad)
|
| gptkbp:bfsLayer |
7
|